According to the Ministry of Health, Brazil currently has 694,000 people on antiretroviral therapy – this year alone, 45,000 people started this treatment against AIDS in the country.
Approved drug represents an advance, as it combines two antiretroviral drugs in a daily dose, which, according to Anvisa, simplifies the treatment and adherence of patients.